Enhance your practice with CME and tools that focus on the management of neurological conditions.
Advancing Pediatric MS Care: Insights from AAN 2026
Elizabeth Wilson, MD
Challenging the Status Quo in Schizophrenia Treatment
Shelina Ramnarine, PhD
Stephen Marder, MD
The Social Brain in Schizophrenia
Michael Green, PhD
Emerging Serum microRNAs as Early Signals in MS
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Christyn Edmundson, MD
Minimal By Design: Define MSE Endpoints
Gil I. Wolfe MD, FAAN
When to Begin FcRn: Initiation Criteria, Key Evidence
Shared Goals, Shared Gains: Align With Patient Preferences
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Escalate With Intention: Stepwise, Target-Anchored Moves
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
May 27, 2026 Miami Beach, Florida
Updates in MS Care: Key Topics at AAN 2026
Aaron Miller, MD
Addressing Social and Systemic Barriers in Schizophrenia
Margaret Emerson, DNP, APRN, PMHNP-BC
Spinal Muscular Atrophy Reveals Hidden Kidney Impairment Risk
Early ALS Patients Show Slowed Decline with Pridopidine Treatment
Nutrition and the Gut-Brain Connection in Schizophrenia
Deanna L. Kelly, PharmD, BCPP
Depression as a Signal of MS Progression
Turning Flares Into Function: Flag Uncontrolled Disease
The IgG Clock: Redose Using IgG Kinetics
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.